𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

✍ Scribed by Sok, J. C.

Book ID
126680510
Publisher
American Association for Cancer Research
Year
2006
Tongue
English
Weight
552 KB
Volume
12
Category
Article
ISSN
1078-0432

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Emerging perspectives in epidermal growt
Emerging perspectives in epidermal growth factor receptor targeting in head and neck cancer
✍ Seungwon Kim; Jennifer R. Grandis; Alessandra Rinaldo; Robert P. Takes; Alfio Fe πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## Abstract The epidermal growth factor receptor (EGFR) has been shown to be a promising therapeutic target in head and neck cancer. Cetuximab, a monoclonal antibody against EGFR, has been approved in the United States for use with radiotherapy for head and neck squamous cell carcinoma. However, th